Contact Us Support Center Language EN - JP - FR - DE

Unlocking the Future of Healthcare: Insights from the 2023 Gartner Report on Digital Transformation

Chet Shemanski

February 9, 2023

General – Blog

The life sciences industry is at the brink of a digital transformation, with economic pressures and disruptive technology and innovation challenging traditional business models. A recent Gartner® report entitled Predicts 2023: Digital Transformation of Healthcare Beckons New Era for Life Sciences is available for complimentary access through Ennov. The report offers insight into the key trends and predictions shaping the future of life sciences.

Get complimentary access to a new Gartner® report every month through Ennov.

One of the key findings is that many life sciences organizations have yet to hit their stride in delivering and demonstrating the value of analytics at scale, despite years of investments in data and technology. On the other hand, digital-first strategies from new entrants and adjacent industries are driving disruptive innovation and putting pressure on established players.

The report also highlights the impact of leading edge technology, such as AI, ML, and cloud infrastructure, on the way drugs are developed and personalized medicine is delivered. Life sciences CIOs are recommended to invest in networks and partnerships, target technology investments that deliver on prioritized business outcomes, and give equal importance to technology as to scientific and laboratory priorities.

As you navigate the rapidly changing landscape of the life sciences industry, Ennov’s team of experts can provide information about our unified solution that can help respond to your specific needs. Contact us today to learn how we can support your digital transformation journey.

Share :

Chet Shemanski

Chet Shemanski is a proven business and information technology professional with extensive experience serving the healthcare and global life sciences industries. He has specific expertise in software product commercialization including product management, product marketing, solution strategy, and alliance management. Chet is a subject matter expert in eClinical and eRegulatory technologies, the author of industry journal articles and a speaker at industry conferences.

Read more posts

Mastering Master Device Data: MDM Benefits for Compliance, Safety, Agility

For medical device companies, accurate and consistent data is critical for regulatory compliance and patient safety. Master Data Management (MDM) is an essential process that

May 10, 2023

Empower Your Quality Management Journey with Gartner Market Guide Insights

The Quality Management System (QMS) landscape is continually transforming, driven by innovative technologies and emerging trends. Discover the essential insights from Gartner’s latest Market Guide

April 26, 2023

Navigating Certified Copies: A Global Guide to FDA, EMA, and Beyond

The clinical trial industry is constantly evolving, with electronic Trial Master Files (eTMF) becoming increasingly popular among sponsors and CROs. By reducing the need for

April 13, 2023

Common Reasons for eCTD Rejection by the FDA and How to Prevent Them

Navigating the complex world of electronic Common Technical Document (eCTD) submissions to the FDA can be a daunting task. Ensuring compliance with FDA regulations and

April 12, 2023

Ennov’s Secret to Consistent Quality

As a leading software company that provides innovative solutions to the life sciences, healthcare, and other regulated industries, we at Ennov understand the importance of

April 11, 2023

Integrated Software: Revolutionizing Customer Complaints and CAPA Management

The pharmaceutical industry plays a critical role in ensuring the health and well-being of people all over the world. With this important responsibility, it is

March 21, 2023

Finding the Right Fit: Key Considerations for Selecting an Integrated Quality Management System

As a Life Sciences professional, finding the right vendor for your integrated document management, learning management, and quality management systems (QMS) is a critical decision.

February 24, 2023

How Mobile EDC is Transforming Clinical Trials in 2023

Electronic Data Capture (EDC) has become an essential part of clinical trials, providing a more efficient way to collect, manage and analyze data. Mobile EDC

January 1, 2023

Managing Post-Approval CMC Changes with RIM & QMS

Perhaps no aspect of Regulatory Information Management (RIM) is more complicated than CMC changes. The published RIM Framework Interim Consensus Paper identifies CMC as a

November 2, 2022

3 Steps to Signal Detection in Pharmacovigilance

There is a growing emphasis on signal detection and signal management in Pharmacovigilance. Companies must be able to manage signals detected: evaluate them to understand

October 5, 2022

Health Canada News Roundup for Reg Affairs-Reg Ops

This year, Health Canada has issued a number of guidance documents (both draft and final) of interest to Reg Affairs and Reg Ops. In this

September 5, 2022

IDMP and RIM: Perfect Together?

Over the last five years or so, Health Authorities have laid the framework for the collection of structured data, rather than just documents, to identify

August 29, 2022

RIM Analytics: Dashboards with a Purpose

Effective Regulatory Information Management involves a constant stream of prioritizations, decision-making, and activity management and monitoring. Effective management occurs when prioritization is risk-based, decisions are

August 22, 2022

FDA News Roundup for Reg Affairs-Reg Ops

In the past six months, the FDA has issued a number of guidance documents (both draft and final) of interested to Reg Affairs and Reg Ops.

August 19, 2022

TMF Completeness: From Chaos to Order

TMF completeness findings are the most commonly reported inspection findings. For example, in them most recently published MHRA GCP inspection report , there were twice

July 21, 2022

5 Myths About eTMF

Managing eTMF (electronic trial master file) is a challenge. However, some organizations impose burdens upon themselves by following practices that aren’t consistent with Health Authority guidance. In

April 14, 2022

4 Ways to Reduce Regulatory Risk Using RIM

If you asked a regulatory colleague about the purpose of a Regulatory Information Management System (RIMS), they might say to provide replacement for spreadsheets, consolidate

February 23, 2022

The Journey to Risk-Based Clinical Analytics

Read the White Paper: Clinical Analytics: The Journey from Problem Identification to Solution Encouraged by Health Authorities, Life Sciences organizations have moved towards risk-based approaches

February 7, 2022

Summary of Updates: Version 2.1 of the EMA IDMP Implementation Guide

With the ever-changing landscape of RIM system compliance, it’s crucial to remain up to speed with the latest guidelines. In this article, discover the changes

January 14, 2022

Interview with Regulatory Expert Steve Clark: Asphalion’s RegTalks RIM Series, Part III

Asphalion, a Scientific and Regulatory Affairs consultancy, hosts a weekly “RegTalk RIMS series”, one-to-one talks carried out by RIMS experts, aimed at informing about the

December 13, 2021

Interview with Regulatory Expert Steve Clark: Asphalion’s RegTalks RIM Series, Part II

Asphalion, a Scientific and Regulatory Affairs consultancy, hosts a weekly “RegTalk RIMS series”, one-to-one talks carried out by RIMS experts, aimed at informing about the

December 2, 2021

Interview with Regulatory Expert Steve Clark: Asphalion’s RegTalks RIM Series, Part I

Asphalion, a Scientific and Regulatory Affairs consultancy, hosts a weekly “RegTalk RIMS series”, one-to-one talks carried out by RIMS experts, aimed at informing about the

November 22, 2021

FDA eCTD-Related News

At Ennov’s recent Regulatory User Group meeting, my colleague Steve Clark provided an update on regulatory news covering the last six months. Our users appreciated

October 14, 2021

Archiving a CRO-Generated eTMF: Considerations for Sponsors

Summary Sponsors receiving TMFs from CRO partners at the end of a study often experience quality issues when attempting to archive the TMFs. This post

July 19, 2021

Brexit Lingers on in the RIM World

“A transition period, during which EU pharmaceutical law as laid out in the ‘Acquis Communautaire’ continued to be applicable to the UK, has ended on 31 December 2020.”

April 22, 2021

FDA News: FDA Updates Various eCTD Documents

Recently, the FDA updated a number of documents related to eCTD. These changes are summarized in the eCTD Submission Standards document, which provides a consolidated

March 24, 2021

MHRA Trial Master File (TMF) GCP Inspection Findings: Trends and Takeaways

On February 12, 2021, The UK Medicines & Healthcare Products Regulatory Agency (MHRA) published their annual GCP Inspections Metrics Report. This report covered the period

February 24, 2021

FDA Removes Two-Way Communication from eCTD 4.0

FDA recently issued updates to their Electronic Common Technical Document (eCTD) v4.0 Technical Conformance Guide; FDA eCTD v4.0 Module 1 Implementation Package. The package was

February 2, 2021

Smart Signal Management in Pharmacovigilance

The evaluation of safety signals should be a continuous process in pharmacovigilance and it is essential that Manufacturing Authorization Holders (MAH’s) have a well-defined process to capture, evaluate,

January 19, 2021

Clinical CAPAs: Are Your Trials in a State of Control?

The MHRA Inspectorate Blog recently posted a post [i] discussing Corrective and Preventive Actions, the importance of root cause analysis, and what triggers inspectors to

January 19, 2021

Preparing for IDMP: Insights from the Gens & Associates survey

Recently, I reviewed the results of the Gens & Associates’ World Class RIM Survey. There is a wealth of great information on RIM investments, benefits, practices,

January 19, 2021

FDA Issues Final Guidance on Civil Money Penalties Relating to ClinicalTrials.gov

FDA has issued a final guidance document on Civil Money Penalties Relating to the ClinicalTrials.gov Data Bank. This draft guidance was first issued in 2018

January 19, 2021

FDA Guidance on Post-marketing Adverse Event Reporting During a Pandemic

The FDA has issued a formal guidance document providing recommendations to industry regarding post-marketing adverse event reporting for drugs, biologics, medical devices, combination products, and dietary

March 25, 2020

Hosting GCP Inspections: Six interesting takeaways from the MHRA’s Blog Post

Recently, the MHRA published a detailed blog post on GCP Inspections: Expectations and the dos and don’ts for hosting. This post includes a lot of

March 10, 2020

Optimize Your eTMF Strategy

I have recently published a peer-reviewed paper called “Optimize Your eTMF Strategy”, that you can read or download on the Journal for Clinical Studies (Volume

December 23, 2019

FDA Eliminates the need for Paper Device Submissions

Recently, the FDA issued a final rule to amend regulations on medical device premarket submissions to remove requirements for paper and multiple copies. Instead, sponsors will

December 18, 2019

6 Considerations for Selecting an EDC Solution

Electronic Data Capture (EDC) solutions have been used for a couple of decades now with more systems available today than one can count. From the

October 19, 2019

Answering Complex Questions with RIM: Helping Sponsors Manage Divestitures

Most people think of Regulatory Information Management (RIM) as a set of tools and processes to manage product submissions and registrations, track regulatory commitments, and

October 10, 2019

Risk-Based Monitoring Improved

On July 17th, the FDA and Duke Margolis Center for Health Policy sponsored a workshop entitled “Improving the Implementation of Risk-Based Monitoring Approaches of Clinical

July 19, 2019

Ennov PV – An Auto-Testing Revolution

[Reading time 5 minutes] Acceptance testing has always been an important part of our lives at Ennov PV. Understandably, our customers have high expectations with

February 13, 2019

EudraVigilance Update, GVP Module IX, and the Impact on Signal Detection

With the release of the new Eudravigilance system on 22nd November 2017, the European Medicines Agency (EMA) have introduced greater access to adverse event data

January 16, 2018

Our Journey with Scrum

[Reading time 10-15 minutes] As we approach our first eighteen months of using the Agile Scrum methodology at Ennov PV, it seems a good time

November 24, 2017

Top 5 eTMF Features | etmf systems

Managing essential documentation for clinical trials has become quite complex in today’s clinical research environment. Study sponsors are required to implement a quality system to

November 24, 2017